Cargando…
Pharmacological conversion of gut epithelial cells into insulin-producing cells lowers glycemia in diabetic animals
As a highly regenerative organ, the intestine is a promising source for cellular reprogramming for replacing lost pancreatic β cells in diabetes. Gut enterochromaffin cells can be converted to insulin-producing cells by forkhead box O1 (FoxO1) ablation, but their numbers are limited. In this study,...
Autores principales: | Du, Wen, Wang, Junqiang, Kuo, Taiyi, Wang, Liheng, McKimpson, Wendy M., Son, Jinsook, Watanabe, Hitoshi, Kitamoto, Takumi, Lee, Yunkyoung, Creusot, Remi J., Ratner, Lloyd E., McCune, Kasi, Chen, Ya-Wen, Grubbs, Brendan H., Thornton, Matthew E., Fan, Jason, Sultana, Nishat, Diaz, Bryan S., Balasubramanian, Iyshwarya, Gao, Nan, Belvedere, Sandro, Accili, Domenico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9754100/ https://www.ncbi.nlm.nih.gov/pubmed/36282594 http://dx.doi.org/10.1172/JCI162720 |
Ejemplares similares
-
SUN-646 A Novel Population of FOXO1-Expressing Cells in the Stomach Controls Cell Plasticity by Regulating the Cyclin CCNE1
por: McKimpson, Wendy M, et al.
Publicado: (2020) -
Chemical induction of gut β-like-cells by combined FoxO1/Notch inhibition as a glucose-lowering treatment for diabetes
por: Kitamoto, Takumi, et al.
Publicado: (2022) -
FOXO1 Is Present in Stomach Epithelium and Determines Gastric Cell Distribution
por: McKimpson, Wendy M., et al.
Publicado: (2022) -
Single-agent FOXO1 inhibition normalizes glycemia and induces gut β-like cells in streptozotocin-diabetic mice
por: Lee, Yun-Kyoung, et al.
Publicado: (2022) -
Reprogramming Cells to Make Insulin
por: McKimpson, Wendy M, et al.
Publicado: (2019)